CD2 Triggering, IFN-γ, but not IL-6, Modulates IL-2 Production
Groups . | IL-2 (pg/mL) . | IL2R+ (%) . |
---|---|---|
Control | Neg | Neg |
Anti-CD3 | 695 ± 10 | 62 ± 5 |
Anti-CD3 + anti-CD2 | 400 ± 85-150 | 30 ± 75-150 |
Anti-CD3 + IFN-γ | 800 ± 155-150 | 75 ± 95-150 |
Anti-CD3 + IL-13 | 685 ± 12 | 61 ± 4 |
Anti-CD3 + IL-6 | 705 ± 4 | 63 ± 5 |
Groups . | IL-2 (pg/mL) . | IL2R+ (%) . |
---|---|---|
Control | Neg | Neg |
Anti-CD3 | 695 ± 10 | 62 ± 5 |
Anti-CD3 + anti-CD2 | 400 ± 85-150 | 30 ± 75-150 |
Anti-CD3 + IFN-γ | 800 ± 155-150 | 75 ± 95-150 |
Anti-CD3 + IL-13 | 685 ± 12 | 61 ± 4 |
Anti-CD3 + IL-6 | 705 ± 4 | 63 ± 5 |
3DO cells were cultured in 96-well plates coated with anti-CD3 MoAb (1 μg/mL) in the presence of cross-linked anti-CD2 MoAb (5 μg/mL), rmIFN-γ (200 U/mL), rmIL-13 (10 ng/mL), or rmIL-6 (20 ng/mL). IL-2 detection by ELISA and IL-2R staining were performed after incubation of 3DO cells for 18 hours. Data are means ± SD of three experiments.
P < .01 comparing line 3 with line 2, and line 4 with line 2.